IBREXAFUNGERP | IBREXAFUNGERP | ATC J02AX07
ANTIINFECTIVES A TRITERPENOID ANTIFUNGAL TREATMENT OF VULVOVAGINAL CANDIDIASIS (VVC) INHIBITS GLUCAN SYNTHASE | ORAL | Cmax 861 NANOMOLAR Tmax 5 HOUR VD 600 LITER PPB 99 PERCENT HT 20 HOUR | GLUCAN SYNTHASE | Unknown - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |